-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
Intuitive Surgical Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$4.36 B | $5.71 B | $6.22 B | $7.12 B | $8.35 B |
| Cost of Revenue |
|
$1.50 B | $1.75 B | $2.03 B | $2.39 B | $2.72 B |
| Gross Profit |
|
$2.86 B | $3.96 B | $4.20 B | $4.73 B | $5.63 B |
| Research & Development |
|
$595.10 M | $671.00 M | $879.00 M | $998.80 M | $1.15 B |
| Selling,General & Administrative |
|
$1.22 B | $1.47 B | $1.74 B | $1.96 B | $2.14 B |
| Operating Expense |
|
$1.81 B | $2.14 B | $2.62 B | $2.96 B | $3.29 B |
| Operating Income |
|
$773.60 M | $1.82 B | $1.21 B | $1.77 B | $2.35 B |
| Net Income |
|
$1.06 B | $1.70 B | $1.32 B | $1.80 B | $2.32 B |
Intuitive Surgical Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$6.87 B | $8.62 B | $6.74 B | $5.22 B | $4.01 B |
| Inventories |
|
$601.50 M | $587.10 M | $893.20 M | $1.22 B | $1.49 B |
| Total Current Assets |
|
$8.12 B | $9.99 B | $8.58 B | $7.89 B | $7.11 B |
| Property,Plant and Equipment |
|
$1.58 B | $1.88 B | $2.37 B | $3.54 B | $4.65 B |
| Goodwill |
|
$336.70 M | $343.60 M | $348.50 M | $348.70 M | $347.50 M |
| Total Assets |
|
$11.17 B | $13.56 B | $12.97 B | $15.44 B | $18.74 B |
| Total Liabilities |
|
$1.41 B | $1.60 B | $1.86 B | $2.04 B | $2.21 B |
| Retained Earnings |
|
$3.26 B | $4.76 B | $3.50 B | $4.74 B | $6.80 B |
| Total Shareholder Equity |
|
$9.76 B | $11.95 B | $11.11 B | $13.31 B | $16.43 B |
| Common Stock |
|
$100.00 K | $400.00 K | $400.00 K | $400.00 K | $400.00 K |
Intuitive Surgical Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$276.20 M | $310.20 M | $365.80 M | $435.20 M | $462.00 M |
| Dividends Payout |
|
- | - | - | - | - |
| Capital Expenditures (Capex) |
|
-$341.50 M | -$353.50 M | -$532.40 M | -$1.06 B | -$1.11 B |
| Free Cash Flow (FCF) |
|
$1.14 B | $1.74 B | $958.40 M | $749.60 M | $1.30 B |
Intuitive Surgical Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$2.86 B | $3.96 B | $4.20 B | $4.73 B | $5.63 B |
| Gross Profit Margin (%) |
|
65.65% | 69.32% | 67.44% | 66.39% | 67.46% |
| Operating Income |
|
$773.60 M | $1.82 B | $1.21 B | $1.77 B | $2.35 B |
| Operating Income Margin (%) |
|
17.75% | 31.89% | 19.47% | 24.80% | 28.12% |
| Net Income |
|
$1.06 B | $1.70 B | $1.32 B | $1.80 B | $2.32 B |
| Net Income Margin (%) |
|
24.33% | 29.85% | 21.25% | 25.24% | 27.81% |
| EBITDA |
|
$1.33 B | $2.13 B | $1.94 B | $2.17 B | $2.67 B |
| EBITDA Margin (%) |
|
30.42% | 37.32% | 31.23% | 30.45% | 32.01% |
Intuitive Surgical Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
10.87% | 14.26% | 11.90% | 13.51% | 14.13% |
| Return on Assets (ROA) |
|
9.50% | 12.58% | 10.19% | 11.64% | 12.39% |
| Debt to Equity |
|
0.82% | 0.73% | 0.84% | 0.67% | - |
| Debt to total asset |
|
0.72% | 0.64% | 0.72% | 0.58% | - |
| Enterprise value to revenue |
|
21.61 | 22.20 | 14.93 | 16.26 | 21.96 |
| Enterprise value to EBITDA |
|
71.02 | 59.47 | 47.81 | 53.40 | 68.58 |
| Enterprise value |
|
$94.18 B | $126.74 B | $92.90 B | $115.82 B | $183.37 B |
| Cash to Debt |
|
1,858.32% | 2,401.61% | 1,589.34% | 2,019.82% | - |
| Tax Rate (%) |
|
11.62% | 8.58% | 16.33% | 7.23% | 12.58% |
| Payout Ratio |
|
- | - | - | - | - |
